Well Mozz. Actually no. They haven’t been granted the patents you think they have. Otherwise, it’d be listed in their annual report along with their COPD patent they have with a failed hay fever trial.
Which brings me to my problem, Mozz. Along with your penchant of picking up primary sources, those that do the hard graft, and changing a few sentences around and then present it as your own research..,,Don’t get me wrong, it’s good for the lazy…..but what really gets me is your drive to adjudicate which opinions pass your judgement in this forum.
you see, you come across as feeling you’re the arbitrator of truth.
”That is correct”
or
”I feel I must add”
As if you have carte Blanche on opinion, abstraction, logical conclusion, and such like. It’s getting tiresome.
Ann: 2021 Annual Report and Appendix 4E, page-60
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $78.73M | |||
| Open | High | Low | Value | Volume |
| 23.0¢ | 23.0¢ | 21.5¢ | $78.13K | 350.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 64880 | 22.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 22.5¢ | 43479 | 1 |
View Market Depth
| Last trade - 16.10pm 11/11/2024 (20 minute delay) ? |
| PAR (ASX) Chart |